Retour
61
Fourchette du Jour
30,20 €
32,91 €
Fourchette 52 Semaines
13,45 €
39,28 €
Volume
1 972 579
Moyenne 50J / 200J
33,65 €
/
29,03 €
Clôture Précédente
32,75 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -24,4 | 0,4 |
| P/B | 2,7 | 2,9 |
| ROE % | -10,9 | 3,7 |
| Net Margin % | -52,0 | 3,9 |
| Rev Growth 5Y % | 67,3 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
46,75 €
+47.8%
Low: 30,00 €
High: 60,00 €
BPA Prévisionnel
-3,97 €
CA Est.
36 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
2,07 €
0,19 € – 4,74 €
|
990 M | 4 |
| FY2029 |
-0,65 €
-1,48 € – -0,06 €
|
570 M | 4 |
| FY2028 |
-2,44 €
-4,01 € – 0,80 €
|
280 M | 10 |
Points Clés
Revenue grew 67,27% annually over 5 years — strong growth
Debt/Equity of 0,03 — conservative balance sheet
Negative free cash flow of -73,47M
PEG of 0,43 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 2957,16%
Capital efficient — spends only 1,08% of revenue on capex
Croissance
Revenue Growth (5Y)
67,27%
Revenue (1Y)3024,43%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-10,92%
ROIC-11,37%
Net Margin-51,99%
Op. Margin-72,84%
Sécurité
Debt / Equity
0,03
Current Ratio11,34
Interest Coverage0,00
Valorisation
P/E Ratio
-24,44
P/B Ratio2,72
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3024,43% | Revenue Growth (3Y) | 205,82% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 67,27% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 218,71M | Net Income (TTM) | -113,70M |
| ROE | -10,92% | ROA | -10,25% |
| Gross Margin | 97,90% | Operating Margin | -72,84% |
| Net Margin | -51,99% | Free Cash Flow (TTM) | -73,47M |
| ROIC | -11,37% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,03 | Current Ratio | 11,34 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -24,44 | P/B Ratio | 2,72 |
| P/S Ratio | 12,70 | PEG Ratio | 0,43 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,78B | Enterprise Value | 2,69B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 218,71M | 7,00M | 23,39M | 50,93M | 27,94M |
| Net Income | -113,70M | -274,48M | -112,96M | -58,66M | -49,76M |
| EPS (Diluted) | -1,28 | -3,36 | -1,96 | -1,42 | -1,41 |
| Gross Profit | 214,12M | 3,17M | 19,38M | 48,83M | 26,22M |
| Operating Income | -159,31M | -326,98M | -134,43M | -62,50M | -50,27M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,11B | 1,12B | 649,32M | 387,97M | 381,35M |
| Total Liabilities | 86,39M | 64,94M | 28,23M | 38,51M | 79,83M |
| Shareholders' Equity | 1,02B | 1,06B | 621,09M | 349,46M | 301,51M |
| Total Debt | 27,91M | 19,17M | 2,87M | 3,48M | 5,18M |
| Cash & Equivalents | 112,83M | 84,38M | 157,02M | 68,63M | 92,05M |
| Current Assets | 666,73M | 689,71M | 532,63M | 370,45M | 251,00M |
| Current Liabilities | 58,82M | 46,07M | 27,10M | 31,72M | 45,16M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#30 of 146
Activité Récente
Entré
Full Throttle
Mar 24, 2026